Zifang Guo
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 10%
- Cancer Research top 10%
- Immunology
- Molecular Biology
- Co-authors
- Javier CortésVassiliki KarantzaCarlos H. BarriosNorikazu MasudaMastura Md YusofSherene LoiMarco Torregroza OteroPeter Schmid
- Topics
- Hepatitis C virus research (12 papers)HIV/AIDS drug development and treatment (10 papers)Cancer Treatment and Pharmacology (5 papers)
- Cited by
- OncologyCancer ResearchImmunology
- Journals
- New England Journal of MedicineJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- United StatesSpainAustralia
In The Last Decade
Zifang Guo
28 papers receiving 1.0k citations
Hit Papers
Peers
Comparison fields: 5 of 92
- Oncology 653
- Pulmonary and Respiratory Medicine 250
- Cancer Research 235
- Immunology 204
- Molecular Biology 118
Countries citing papers authored by Zifang Guo
This map shows the geographic impact of Zifang Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zifang Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zifang Guo more than expected).
Fields of papers citing papers by Zifang Guo
This network shows the impact of papers produced by Zifang Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zifang Guo. The network helps show where Zifang Guo may publish in the future.
Co-authorship network of co-authors of Zifang Guo
This figure shows the co-authorship network connecting the top 25 collaborators of Zifang Guo. A scholar is included among the top collaborators of Zifang Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zifang Guo. Zifang Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 28 | |
| 4 | 1 | |
| 5 | 7 | |
| 6 | Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancerbreakdown → | 594 |
| 7 | 5 | |
| 8 | 18 | |
| 9 | 137 | |
| 10 | 113 | |
| 11 | 10 | |
| 12 | 5 | |
| 13 | 14 | |
| 14 | 4 | |
| 15 | 3 | |
| 16 | 5 | |
| 17 | 7 | |
| 18 | 1 | |
| 19 | 7 | |
| 20 | 33 |
About Zifang Guo
Zifang Guo is a scholar working on Hepatology, Infectious Diseases and Statistics and Probability, having authored 30 papers that have together received 1.0k indexed citations. Recurring topics across this work include Hepatitis C virus research (12 papers), HIV/AIDS drug development and treatment (10 papers) and Cancer Treatment and Pharmacology (5 papers). The work is most often cited by research in Oncology (653 citations), Cancer Research (235 citations) and Immunology (204 citations). Zifang Guo has collaborated with scholars based in United States, Spain and Australia. Frequent co-authors include Javier Cortés, Vassiliki Karantza, Carlos H. Barrios, Norikazu Masuda, Mastura Md Yusof, Sherene Loi, Marco Torregroza Otero, Peter Schmid, Seock‐Ah Im and Hope S. Rugo. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.